• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

European Biopharmaceutical Enterprises Announces New Board

Article

June 16, 2016.

European Biopharmaceutical Enterprises, EBE, has announced its Board of Directors for the term 2016–2018, following the EBE and EFPIA (European Federation of Pharmaceutical Industries and Associations) Annual Meetings this week.

EBE members appointed a 13-strong C-level board headed by Eduardo Bravo, CEO of TiGenix, who previously served as EBE Vice-President. Mr. Andrea Chiesi - currently Vice President of Holostem Advanced Therapies and Director R&D Project Portfolio Management at Chiesi Farmaceutici - will support Mr Bravo as EBE Vice President. Didier Malherbe, Vice President of Public Affairs, UCB and Managing Director UCB Belgium, was re-elected as Treasurer of EBE.

The full EBE board is illustrated below.

Related Videos
Related Content
Abid Rahman

Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA

April 19th 2024
Article

Rahman discusses the new opportunities that digital twins present to researchers.

UniDoc

UniDoc Brings AI-Powered Health Cube to Alaska

April 17th 2024
Article

The Health Cube will increase remote and virtual care options for populations living in remote areas.

Riccardo Butta

At-Home Patients and AI: Q&A with Riccardo Butta

April 16th 2024
Article

Butta discusses how new technologies are being implemented in at-home devices.

Say Hello to Flexible: Reimagining the Patient Journey

Say Hello to Flexible: Reimagining the Patient Journey

April 15th 2024
Article

Through embracing connected and tech-enabled services and devices, new avenues and opportunities exist for greater clinical trial flexibility in drug research.

Stock.adobe.com

ArisGlobal Announces Second Life Sciences Generative AI Council Session

April 11th 2024
Article

The meeting is scheduled for May in Switzerland.

Image credit: ArtemisDiana | stock.adobe.com

Precision Medicine: Investments and Outcomes Expected

March 18th 2024
Article

Precision medicine is now seen as a healthcare approach for both the present and the future, particularly with the explosion of personalized care delivery.